Amarin Neuroscience Ltd.
🇬🇧United Kingdom
Clinical Trials
7
Active:6
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Phase 3
Completed
- Conditions
- Huntington Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2007-12-27
- Lead Sponsor
- Amarin Neuroscience Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT00146211
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸University of California San Diego, La Jolla, California, United States
News
No news found